Praxis Precision Medicines, Inc.
(NASDAQ : PRAX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.37%36.390.9%$1785.49m
ABBVAbbVie, Inc. 1.94%104.161.9%$1056.38m
JNJJohnson & Johnson 0.04%143.930.7%$1032.19m
LLYEli Lilly & Co. 0.95%144.741.1%$717.15m
MRKMerck & Co., Inc. 0.06%80.330.7%$695.27m
BMYBristol-Myers Squibb Co. 2.16%63.261.0%$694.96m
AZNAstraZeneca Plc -1.77%53.731.2%$283.31m
GSKGlaxoSmithKline Plc 1.09%37.140.2%$232.28m
NVSNovartis AG 1.02%88.200.2%$182.31m
NVONovo Nordisk A/S -1.97%66.070.1%$92.56m
RGENRepligen Corp. -2.99%180.317.1%$87.88m
SNYSanofi 0.22%49.960.2%$74.65m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 3.05%91.180.0%$65.89m
RPRXRoyalty Pharma Plc -1.03%39.790.2%$65.15m
ARCTArcturus Therapeutics Holdings, Inc. -1.09%60.640.0%$56.60m

Company Profile

Praxis Precision Medicines, Inc. is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders. The company was founded by Kiran Reddy, David Goldstein and Steven Petrou on September 22, 2015 and is headquartered in Cambridge, MA.